ImmunogenX Acquires Alvine Pharmaceuticals for Undisclosed Sum

  • Feed Type
  • Date
    3/16/2016
  • Company Name
    Alvine Pharmaceuticals
  • Mailing Address
    75 Shoreway Rd San Carlos, CA 94070 USA
  • Company Description
    Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
  • Website
    http://www.alvinepharma.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The asset acquired was Latiglutenase (formerly known as ALV003 and renamed IMGX-003), an orally administered mixture of two recombinant gluten-specific proteases that degrades gluten proteins into small physiologically irrelevant fragments.

Trending on Xconomy